180 related articles for article (PubMed ID: 30197416)
1. Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study.
Lentferink YE; van der Aa MP; van Mill EGAH; Knibbe CAJ; van der Vorst MMJ
Nutr Diabetes; 2018 Sep; 8(1):47. PubMed ID: 30197416
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
[TBL] [Abstract][Full Text] [Related]
3. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.
Wiegand S; l'Allemand D; Hübel H; Krude H; Bürmann M; Martus P; Grüters A; Holl RW
Eur J Endocrinol; 2010 Oct; 163(4):585-92. PubMed ID: 20639355
[TBL] [Abstract][Full Text] [Related]
4. The effects of metformin on insulin resistance in overweight or obese children and adolescents: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.
Sun J; Wang Y; Zhang X; He H
Medicine (Baltimore); 2019 Jan; 98(4):e14249. PubMed ID: 30681616
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial.
van der Aa MP; Hoving V; van de Garde EM; de Boer A; Knibbe CA; van der Vorst MM
J Obes; 2016; 2016():7852648. PubMed ID: 28101379
[No Abstract] [Full Text] [Related]
6. Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.
Stagi S; Ricci F; Bianconi M; Sammarco MA; Municchi G; Toni S; Lenzi L; Verrotti A; de Martino M
Nutrients; 2017 May; 9(5):. PubMed ID: 28531113
[No Abstract] [Full Text] [Related]
7. Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents.
Juárez-López C; Klünder-Klünder M; Madrigal-Azcárate A; Flores-Huerta S
Pediatr Diabetes; 2013 Aug; 14(5):377-83. PubMed ID: 23438101
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Metformin for Weight Reduction in Children and Adolescents Treated with Mixed Dopamine and Serotonin Receptor Antagonists: A Naturalistic Cohort Study.
Levy-Shraga Y; Madi LR; Shalev M; Mazor-Aronovitch K; Schwartz-Lifshitz M; Gothelf D
J Child Adolesc Psychopharmacol; 2021 Jun; 31(5):376-380. PubMed ID: 33887146
[No Abstract] [Full Text] [Related]
9. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children.
Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
Pediatr Diabetes; 2015 Nov; 16(7):538-45. PubMed ID: 25332100
[TBL] [Abstract][Full Text] [Related]
10. Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus.
Bjornstad P; Schäfer M; Truong U; Cree-Green M; Pyle L; Baumgartner A; Garcia Reyes Y; Maniatis A; Nayak S; Wadwa RP; Browne LP; Reusch JEB; Nadeau KJ
Circulation; 2018 Dec; 138(25):2895-2907. PubMed ID: 30566007
[TBL] [Abstract][Full Text] [Related]
11. A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension.
Handen BL; Anagnostou E; Aman MG; Sanders KB; Chan J; Hollway JA; Brian J; Arnold LE; Capano L; Williams C; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Peleg N; Odrobina D; McAuliffe-Bellin S; Marler S; Wong T; Wagner A; Hadjiyannakis S; Macklin EA; Veenstra-VanderWeele J
J Am Acad Child Adolesc Psychiatry; 2017 Oct; 56(10):849-856.e6. PubMed ID: 28942807
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.
Yanovski JA; Krakoff J; Salaita CG; McDuffie JR; Kozlosky M; Sebring NG; Reynolds JC; Brady SM; Calis KA
Diabetes; 2011 Feb; 60(2):477-85. PubMed ID: 21228310
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Metformin for Obesity: A Systematic Review.
Masarwa R; Brunetti VC; Aloe S; Henderson M; Platt RW; Filion KB
Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33608415
[TBL] [Abstract][Full Text] [Related]
15. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with metformin and fenofibrate for insulin resistance in obesity.
Li XM; Li Y; Zhang NN; Xie YH; Shi YQ
J Int Med Res; 2011; 39(5):1876-82. PubMed ID: 22117989
[TBL] [Abstract][Full Text] [Related]
17. Metformin in the Management of Childhood Obesity: A Randomized Control Trial.
Warnakulasuriya LS; Fernando MMA; Adikaram AVN; Thawfeek ARM; Anurasiri WL; Silva RR; Sirasa MSF; Rytter E; Forslund AH; Samaranayake DL; Wickramasinghe VP
Child Obes; 2018; 14(8):553-565. PubMed ID: 30070925
[TBL] [Abstract][Full Text] [Related]
18. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of the benefits and risks of metformin in treating obesity in children aged 18 years and younger.
McDonagh MS; Selph S; Ozpinar A; Foley C
JAMA Pediatr; 2014 Feb; 168(2):178-84. PubMed ID: 24343296
[TBL] [Abstract][Full Text] [Related]
20. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial.
Atabek ME; Pirgon O
J Pediatr Endocrinol Metab; 2008 Apr; 21(4):339-48. PubMed ID: 18556965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
